1. Home
  2. CMRE vs ADMA Comparison

CMRE vs ADMA Comparison

Compare CMRE & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Costamare Inc. $0.0001 par value

CMRE

Costamare Inc. $0.0001 par value

HOLD

Current Price

$17.30

Market Cap

2.0B

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$8.39

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMRE
ADMA
Founded
1974
2004
Country
Monaco
United States
Employees
1880
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.4B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
CMRE
ADMA
Price
$17.30
$8.39
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$12.00
$25.67
AVG Volume (30 Days)
422.1K
6.6M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
3.10%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.19
Revenue
N/A
$42,219,783.00
Revenue This Year
N/A
$27.46
Revenue Next Year
N/A
$22.11
P/E Ratio
$5.55
$43.34
Revenue Growth
N/A
43.85
52 Week Low
$8.19
$7.21
52 Week High
$18.06
$22.37

Technical Indicators

Market Signals
Indicator
CMRE
ADMA
Relative Strength Index (RSI) 53.35 32.49
Support Level $16.08 $7.34
Resistance Level $17.76 $16.02
Average True Range (ATR) 0.59 0.53
MACD 0.06 -0.08
Stochastic Oscillator 70.83 26.25

Price Performance

Historical Comparison
CMRE
ADMA

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and others. The company provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: